75N95024C00021↗

Name: 75N95024C00021: Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders.
Creator: SpendQuery

ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS.

Definitive Contract · National Institutes of Health · to Research Triangle Institute (UEI JJHCMK4NT5N3) · data as of 2026-09-30

Obligated to date$1.85M7 actions

Current value$1.85Mwith options exercised

Potential value$7.02Mif every option is used

Period2024-08-04 → 2027-08-03up to 2029-08-03 with options

Passed on$58.4Kto 1 subcontractor

Up for re-bid: ends 2027-08-03. Recompete brief → · CTN Data, Statistics, and Clinical Trial Support Center (DSC7) ↗

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: National Institutes of Health Nida (75N950)
Competition: Full and open competition · 1 offer received
Pricing: Cost plus fixed fee
How it was bought: Standalone contract
Solicitation: 75N95024R00045
Where the work is: Durham, NC · district NC-04
Topics: opioids

Obligations by fiscal year

FY2024$747.6K

FY2025$543.7K

FY2026$561.1K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

1 subaward totaling $58.4K (3.2% of what was obligated), as Research Triangle Institute reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.

Subcontractor	Amount	Subawards	Where	First	Last
Thermo Fisher Scientific Inc.	$58.4K	1	GA	2025-08-04	2025-08-04

The largest single subawards

Date	To	Amount	For
2025-08-04	Fisher Scientific Company LLC	$58.4K	PO RTI1000442

Every action

7 actions since 2024-08-01. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-04	P00006	Administrative change	$0	EO14398. ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2027.
2026-05-08	P00005	Option exercised	$561.1K	ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2027.
2026-03-13	P00004	Administrative change	$0	ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026.
2026-02-20	P00003	Administrative change	$0	ACST OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026.
2025-07-21	P00002	Change order	$543.7K	EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI ACST OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2024 - AUGUST 3, 2026.
2024-09-18	P00001	Funding only	$747.6K	ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS.
2024-08-01	0		$0	ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗